Vivimed Labs acquires 100% equity stake in Klar Sehen

Vivimed Labs, in a bid to consolidate its segment of domestic pharmaceutical business, has acquired 100% equity stake in Klar Sehen (KSPL).  Vivimed's acquisition of KSPL complements its strategy to increase its domestic presence in specialty pharmaceutical areas, its extensive knowledge and experience in manufacturing, R&D will help grow this business to new levels.

KSPL is a 30 year old Kolkata based Pharmaceutical Company with strong marketing presence in North East, Bihar and Andhra Pradesh. KSPL operates in a niche ophthalmic segment and owns about 50 trademarks and some very well known brands such as Renicol, Lysicon-V, Care Tears, Dexacort etc, in eye care segment. KSPL has cGMP compliant manufacturing facilities at Kolkata, Hyderabad and also has arrangements to manufacture some of its products in Uttaranchal. KSPL presently operates from its headquarters in Kolkata with over 150 medical sales professionals.

In a research conducted by C-Marc (India) for the period Nov-Feb 2011, KSPL for its wide range of Ophthalmic products has bagged an all India corporate standing rank of no 1 in the East Zone and bagged a rank of no 5 in India (in Indian, Dist HQ & Extra-Urban and rural markets).

Vivimed Labs is engaged in the business of manufacturing ingredients for the home and personal care (H&PC) industry and Contract Research and Manufacturing Services (CRAMS). It carries on its business from 4 manufacturing facilities which are located at Bidar (Karnataka), Jeedimetla (Hyderabad), Bonthapally (Hyderabad) and Kashipur (Uttaranchal).